Physician profile
Abbey Benold
NPI 1679273601
$794.75
in general payments reported to CMS, 2019-2025
11 companies · $18.92 in 2025
The $18.92 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $482 · 2024: $294 · 2025: $18.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $794.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $303.74 | 2023-2024 | Orgovyx, Gemtesa |
| Dendreon Pharmaceuticals LLC | $129.76 | 2023-2024 | Provenge |
| Novartis Pharmaceuticals Corporation | $75.99 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $69.49 | 2023 | Prolaris |
| Progenics Pharmaceuticals, INC. | $66.97 | 2023-2024 | Pylarify |
| Merck Sharp & Dohme LLC | $40.19 | 2024 | Keytruda |
| Boston Scientific Corporation | $31.76 | 2023 | Spaceoar Vue System - 10ml |
| Foundation Medicine, INC. | $26.51 | 2023 | |
| Axonics, INC. | $17.99 | 2023 | Axonics, Bulkamid |
| Astrazeneca Pharmaceuticals LP | $17.06 | 2023 | Lynparza |
| Endo Pharmaceuticals INC. | $15.29 | 2023 | Edex, Xiaflex, Aveed |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abbey Benold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.